APA (7th ed.) Citation

Barreto Miranda, M., Proetel, U., Fabarius, A., Hofmann, W., Müller, M. C., Hehlmann, R., & Saußele, S. (2016). Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: Long-term observation in CML Study IV. Leukemia, 30(6), . https://doi.org/10.1038/leu.2016.20

Chicago Style (17th ed.) Citation

Barreto Miranda, Manuel, Ulrike Proetel, Alice Fabarius, Wolf-Karsten Hofmann, Martin Christian Müller, Rüdiger Hehlmann, and Susanne Saußele. "Secondary Malignancies in Chronic Myeloid Leukemia Patients After Imatinib-based Treatment: Long-term Observation in CML Study IV." Leukemia 30, no. 6 (2016). https://doi.org/10.1038/leu.2016.20.

MLA (9th ed.) Citation

Barreto Miranda, Manuel, et al. "Secondary Malignancies in Chronic Myeloid Leukemia Patients After Imatinib-based Treatment: Long-term Observation in CML Study IV." Leukemia, vol. 30, no. 6, 2016, https://doi.org/10.1038/leu.2016.20.